Le Lézard
Classified in: Health, Science and technology, Business, Covid-19 virus
Subjects: CSR, SRI, CFG

Government of Canada advances domestic life sciences sector by supporting Canadian companies, talent, and research and development

A $92 million investment in adMare BioInnovations will help translate health research into innovative new therapies in Canada

VANCOUVER, BC, March 30, 2022 /CNW/ - Protecting the health and safety of Canadians and making sure we have the domestic capacity to respond to future health crises are top priorities of the Government of Canada. With the guidance of Canada's Biomanufacturing and Life Sciences Strategy, the government is actively supporting the growth of a strong, competitive domestic life sciences sector, with cutting-edge biomanufacturing capabilities. 

Today, the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, announced a $92 million investment in adMare BioInnovations to drive company innovation, scale-up and training activities in Canada's life sciences sector. This investment will help translate commercially promising health research into innovative new therapies and will see Canadian anchor companies provide the training required and drive the growth of Canada's life science companies.

Through adMare's innovation centres in Vancouver and Montréal, entrepreneurs, academic researchers, innovators and emerging Canadian small and medium-sized enterprises (SME) can access a full spectrum of services, including scientific expertise, research infrastructure and business development support, as well as funding for new research and development projects with strong commercial potential.

Canada is growing its diverse talent pipeline and research systems while attracting industry leaders to transform innovative ideas into the scientific discoveries of tomorrow. The government will continue to focus on improving the health outcomes of Canadians, relaunching the economy and providing well-paying jobs to Canadians.


"Today's investment in adMare BioInnovations is another step forward as we continue the work of building back our biomanufacturing sector after a 40-year decline. We know that by investing in Canadian entrepreneurs, researchers, scientists and innovators, Canada will be well prepared for future pandemics and health emergencies. It is through Canadian talent and businesses that we will solve our world's toughest problems and make Canada a hub for life sciences and biomanufacturing."
? The Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry

"adMare greatly appreciates the strong support the Government of Canada has shown, not only to our organization but also to Canada's entire life sciences enterprise. The historic investments Canada has made will significantly enhance adMare's ability to deliver on our mission of building companies, building ecosystems and building talent?as well as advance the ambitious goals set out in Canada's Biomanufacturing and Life Sciences Strategy. Today, we have an unprecedented opportunity to make Canada a global life sciences leader, and together with our partners in government, academia, industry and the investment community, we look forward to realizing that vision."
? Gordon C. McCauley, President and CEO, adMare BioInnovations

Quick facts
Associated links
Stay connected

Find more services and information at Canada.ca/ISED.
Follow @CDNScience on social media for Canadian science news: Twitter, Instagram, Facebook

SOURCE Innovation, Science and Economic Development Canada

These press releases may also interest you

at 00:14
Hong Kong Aerospace Technology Group Limited (01725. HK) has been actively preparing for mass production since the beginning of this summer, following the signing of fit-out contracts for the construction of the Satellite Manufacturing Center, and...

at 00:06
-  Baidu has become the first and only company to offer fully driverless robotaxi services to the public in China, without human drivers in the car. -  The new permits will also allow Baidu to put fully driverless robotaxis on open roads in Chongqing...

7 aoû 2022
NuZee, Inc. , a leading U.S. producer and co-packer of single serve coffee formats, today announced the pricing of its underwritten public offering of 4,200,000 shares of its common stock at a public offering price of $0.82 per share, resulting in...

7 aoû 2022
Global investment firm The Carlyle Group Inc. ("Carlyle" or "the Company") today announced changes in its executive leadership team. With...

7 aoû 2022
The demand for mobile point-of-sale (mPOS)...

7 aoû 2022
Earlier today the Senate voted to pass the Inflation Reduction Act of 2022, a bill that includes several key provisions to lower the prices of prescription drugs. AARP Illinois thanks Senators Tammy Duckworth and Senate Majority Whip Dick Durbin for...

News published on 30 march 2022 at 12:00 and distributed by: